Xiaoxiang Rong

1.7k total citations
28 papers, 859 citations indexed

About

Xiaoxiang Rong is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Xiaoxiang Rong has authored 28 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Xiaoxiang Rong's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Xiaoxiang Rong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Xiaoxiang Rong collaborates with scholars based in China, United States and Singapore. Xiaoxiang Rong's co-authors include Wangjun Liao, Min Shi, Jianping Bin, Yulin Liao, Jingwen Zhang, Rui Zhou, Dongqiang Zeng, Huiying Sun, Jianhua Wu and Na Huang and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Oncogene.

In The Last Decade

Xiaoxiang Rong

24 papers receiving 851 citations

Peers

Countries citing papers authored by Xiaoxiang Rong

Since Specialization

Citations

This map shows the geographic impact of Xiaoxiang Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiang Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiang Rong more than expected).

Fields of papers citing papers by Xiaoxiang Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiang Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiang Rong. The network helps show where Xiaoxiang Rong may publish in the future.

Co-authorship network of co-authors of Xiaoxiang Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiang Rong. A scholar is included among the top collaborators of Xiaoxiang Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiang Rong. Xiaoxiang Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single cell RNA sequencing reveals the reshaping effect of perfluorooctanoic acid on the intestinal microenvironment of mice 2025 ·Ecotoxicology and Environmental Safety ·(unknown), (unknown), Rui Zhou, (unknown), (unknown), Ke Yang, (unknown), (unknown), Siting Zheng, Zhenhua Huang, Xiaoxiang Rong	0
2	Multi-omics investigation of Bisphenol A in gastrointestinal carcinogenesis: a network toxicology and molecular docking approach 2025 ·Environment International ·(unknown), Ke Yang, (unknown), (unknown), Ya Gao, Yue Huang, Rui Zhou, Zhenhua Huang, (unknown), Tao Li, Baoxiong Zhuang, Xiaoxiang Rong	0
3	Multiple-omics analysis reveals a dedifferentiation-immune loop in intrahepatic cholangiocarcinoma 2025 ·Molecular Therapy ·Jian Ruan, Qiong Li, Yuzhi Jin, Jie Yin, Chanqi Ye, Fei Cheng, Shuaishuai Xu, (unknown), (unknown), Xiaoxiang Rong, Ming Jiang, Wenguang Fu, Dayong Zheng, Jinzhang Chen, Xuanwen Bao, (unknown), Jianpeng Sheng, Peng Zhao	2
4	Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts 2022 ·Frontiers in Immunology ·Guosheng Yuan, (unknown), (unknown), Qi Li, Rong Li, Xiao Hu, Mengya Zang, Xiao Cheng, Guanting Lu, (unknown), Wenzhe Fan, Xiaoxiang Rong, Jian Sun, Jinzhang Chen	7
5	Cross talk between acetylation and methylation regulators reveals histone modifier expression patterns posing prognostic and therapeutic implications on patients with colon cancer 2022 ·Clinical Epigenetics ·Rui Zhou, (unknown), (unknown), (unknown), Xuemei Chen, Jinzhang Chen, Shaoyan Xi, Zhenhua Huang, Xiaoxiang Rong	13
6	Hepatic Tumor Stiffness Measured by Shear Wave Elastography is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts 2022 ·SSRN Electronic Journal ·Guosheng Yuan, (unknown), (unknown), (unknown), Rong Li, Xiao Hu, Mengya Zang, Xiao Cheng, Guanting Lu, Jing Huang, Wenzhe Fan, Xiaoxiang Rong, Jian Sun, Jinzhang Chen	1
7	PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients 2022 ·Frontiers in Oncology ·Xiaoxiang Rong, (unknown), (unknown), Zhaojun Wang, Dongqiang Zeng, (unknown), Shao-wei Li, Jian Wu, Zheyu Shen, Min Shi, Wangjun Liao, Zhenhua Wu, Chunlin Wang	22
8	CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy 2021 ·Oncogene ·(unknown), Rui Zhou, Yannan Zheng, Zhaowei Wen, (unknown), Dongqiang Zeng, Jianhua Wu, Zhenhua Huang, Xiaoxiang Rong, Na Huang, Li Sun, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao	23
9	Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific Chemotherapy 2021 ·Nano Letters ·Lin Huang, Jie Feng, Wenpei Fan, Wei Tang, Xiaoxiang Rong, Wangjun Liao, Zhenni Wei, Yikai Xu, Aiguo Wu, Xiaoyuan Chen, Zheyu Shen	43
10	A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer 2020 ·Journal of Cellular and Molecular Medicine ·Rui Zhou, Huiying Sun, Siting Zheng, Jingwen Zhang, Dongqiang Zeng, Jianhua Wu, Zhenhua Huang, Xiaoxiang Rong, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao	13
11	Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation 2020 ·Journal of Experimental & Clinical Cancer Research ·Qiong Huang, Shao-wei Li, Xingbin Hu, Mengting Sun, Qijing Wu, (unknown), (unknown), Fei Sun, Chunlin Wang, Xiaoxiang Rong, Wangjun Liao, Jianjun Peng, Jianjun Xiao, Li Huang, Jiao Wang, Bishan Liang, (unknown), Yajing Liu, Min Shi	44
12	FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma 2020 ·Cancer Cell International ·Qing Chen, Xiaoxiang Rong, Xinhui Liu, Dayong Zheng, (unknown), Fengsheng Chen, Peng Zhao, Feiye Liu, Jian Ruan	8
13	miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer 2019 ·Molecular Therapy ·Yuhao Luo, Jianhua Wu, Qianying Wu, Xiaoyin Li, (unknown), Jingwen Zhang, Xiaoxiang Rong, (unknown), Yulin Liao, Jianping Bin, Na Huang, Wangjun Liao	43
14	Role of systemic inflammatory response in evaluating the prognosis of patients with osteosarcoma 2018 ·Zhenhua Huang, Yang Chen, (unknown), (unknown), Xiaoxiang Rong	1
15	Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer 2018 ·Cancer Immunology Immunotherapy ·Rui Zhou, Jingwen Zhang, Dongqiang Zeng, Huiying Sun, Xiaoxiang Rong, Min Shi, Jianping Bin, Yulin Liao, Wangjun Liao	186
16	MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer 2017 ·Molecular Cancer ·Feiye Liu, (unknown), Xiaoxiang Rong, Jinzhang Chen, Dayong Zheng, Lu Chen, Junyi Zhang, Rongcheng Luo, Peng Zhao, Jian Ruan	60
17	Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway 2016 ·Medicine ·Raoying Xie, Xiaolin Lin, Tao Du, Kang Xu, Hong-Fen Shen, Wei Fang, Wei-Chao Hao, Taoyan Lin, Xia Lin, Yujuan Qin, Huiyan Wang, Lin Chen, Sheng Yang, Jie Yang, Xiaoxiang Rong, Kai‐Tai Yao, Dong Xiao, Jun-Shuang Jia, Yan Sun	55
18	The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma 2015 ·Medicine ·Xiaoxiang Rong, Wei Fang, Qian Geng, Jian Ruan, (unknown), Aimin Li, Rongcheng Luo	20
19	Positron emission tomography‐computed tomography on predicting the efficacy of targeted therapy for lung adenocarcinoma 2014 ·Thoracic Cancer ·Xiaoxiang Rong, Xiaoli Cai, Rong Li, Jinzhang Chen, Quanshi Wang, Changxuan You, (unknown), Chuanxin Liu, Junyi Zhang, Rongcheng Luo	5
20	Effective activity of cytokine induced killer cells against hepatocellular carcinoma including tumor-initiating cells 2014 ·Medical Hypotheses ·Xiaoxiang Rong, Wei Fang, Aimin Li, Dong Xiao, Rongcheng Luo	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact